These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation. Petrides PE; Gisslinger H; Steurer M; Linkesch W; Krumpl G; Schüller A; Widmann R Clin Ther; 2009 Feb; 31(2):386-98. PubMed ID: 19302911 [TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin serum concentration in patients with reactive and myeloproliferative thrombocytosis. Uppenkamp M; Makarova E; Petrasch S; Brittinger G Ann Hematol; 1998 Nov; 77(5):217-23. PubMed ID: 9858147 [TBL] [Abstract][Full Text] [Related]
13. Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis. Wang JC; Chen C; Novetsky AD; Lichter SM; Ahmed F; Friedberg NM Am J Med; 1998 May; 104(5):451-5. PubMed ID: 9626028 [TBL] [Abstract][Full Text] [Related]
14. In vitro studies of megakaryocytopoiesis in thrombocytotic disorders of man. Gewirtz AM; Bruno E; Elwell J; Hoffman R Blood; 1983 Feb; 61(2):384-9. PubMed ID: 6821705 [TBL] [Abstract][Full Text] [Related]
15. Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia. Thiele J; Funke S; Holgado S; Choritz H; Georgii A Anal Quant Cytol; 1984 Sep; 6(3):155-67. PubMed ID: 6594964 [TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin levels in patients with primary and reactive thrombocytosis. Cerutti A; Custodi P; Duranti M; Noris P; Balduini CL Br J Haematol; 1997 Nov; 99(2):281-4. PubMed ID: 9375739 [TBL] [Abstract][Full Text] [Related]
17. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group. Michiels JJ; Juvonen E Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350 [TBL] [Abstract][Full Text] [Related]
18. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile. Steurer M; Gastl G; Jedrzejczak WW; Pytlik R; Lin W; Schlögl E; Gisslinger H Cancer; 2004 Nov; 101(10):2239-46. PubMed ID: 15476273 [TBL] [Abstract][Full Text] [Related]
19. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders. Wehmeier A; Südhoff T; Meierkord F Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357 [TBL] [Abstract][Full Text] [Related]